B Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Higher Gold Prices CRDL Q4 2025 Earnings Narrower Than Expected Loss as Cardiol Therapeutics Advances Clinical Pipeline CLS Q1 2026 Earnings EPS Beat Drives Stock Uptick TTWO Q1 2026 Earnings Earnings Beat Fails to Lift Shares as Market Digests Outlook MSFT Q1 2026 Earnings Solid EPS Beat Offsets Modest Revenue Headwinds HCTI Q4 2025 Earnings Staggering EPS Miss Driven by Deepening Losses